The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices
Fler avsnitt av Ones and Tooze
Visa alla avsnitt av Ones and ToozeOnes and Tooze med Foreign Policy finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
